Clinical Trial Endpoints in Cancer Research: Four Terms You Should Know
COTELLIC® (cobimetinib) + ZELBORAF® (vemurafenib) Objective Response Rate
Nexcella Announces Positive 58-Patient NXC- 201 Clinical Data: 100% Overall Response Rate in light chain (AL) Amyloidosis; 92% Overall Response Rate in Multiple Myeloma at the EBMT 49th Annual Meeting in Paris | BioSpace
BRAFTOVI + cetuximab | Overall Response Rate | ORR | BEACON CRC
Predicting Successful Phase Advancement and Regulatory Approval in Multiple Myeloma From Phase I Overall Response Rates | JCO Clinical Cancer Informatics
Comparing Outcomes in Patients with Recurrent or Refractory Ovarian Cancer Managed with 1 of 2 Versions of Pegylated Liposomal Doxorubicin at an Academic Medical Center
Efficacy Data | KYMRIAH® (tisagenlecleucel) for DLBCL | HCP
Efficacy endpoints in Oncology
Objective response rate of placebo in randomized controlled trials of anticancer medicines - eClinicalMedicine
Overall Response Rates - WM | IMBRUVICA® (ibrutinib) HCP
Response Rates for Waldenström Macroglobulinemia Improve With Use of New First-Line, Better-Tolerated Treatments - U.S. Medicine
Overall Response Rate in Previously Untreated CLL | CALQUENCE® (acalabrutinib) 100 mg tablets | For HCPs
ODOMZO® (sonidegib) | Efficacy Data
Efficacy I PLUVICTO
Extremely High Objective Response Rate of Lenvatinib: Its Clinical Relevance and Changing the Treatment Paradigm in Hepatocellular Carcinoma | Semantic Scholar
Efficacy | Tivdak® (tisotumab vedotin-tftv)
Durable Response Rate
Objective response rate assessment in oncology: Current situation and future expectations
Overall response rate | Download Table
Durable Response Rate
Clinical Trial Endpoints in Cancer Research: Four Terms You Should Know
ORR (Objective Response Rate) and related statistics – Part 1
What Low Response Rates Mean for Telephone Surveys | Pew Research Center
Cell therapy doubles survival, response rates in advanced melanoma
Forest plot of the comparison of overall response rate (ORR).
